Michael Crump
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 194
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 67
- Oncology top 0.2%
- Viral-associated cancers and disorders 58
- CAR-T cell therapy research 32
- Cancer Treatment and Pharmacology 20
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment 39
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 21
-
- Lung Cancer Treatments and Mutations 39
- Co-authors
- John KuruvillaArmand KeatingMelania PintilieRichard TsangChristian GisselbrechtDavid HodgsonMary GospodarowiczWoodrow Wells
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Michael Crump
292 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Pathology and Forensic Medicine 5.6k
- Genetics 2.4k
- Oncology 5.3k
- Neurology 1.5k
- Hematology 1.0k
Countries citing papers authored by Michael Crump
This map shows the geographic impact of Michael Crump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Crump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Crump more than expected).
Fields of papers citing papers by Michael Crump
This network shows the impact of papers produced by Michael Crump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Crump. The network helps show where Michael Crump may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Crump, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 18 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 45 | |
| 10 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studybreakdown → | 2017 | 1042 |
| 11 | 2016 | 28 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 28 | |
| 14 | Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Studybreakdown → | 2011 | 439 |
| 15 | 2007 | 29 | |
| 16 | Oncodiagnosis panel: 2004 lymphoma | 2006 | 1 |
| 17 | Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL). | 2002 | 1 |
| 18 | Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells. | 1997 | 2 |
| 19 | Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up. | 1996 | 1 |
| 20 | Nutritional factors in the pathogenesis of proliferative enteritis and swine dysentery. | 1990 | 1 |
About Michael Crump
Michael Crump is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 310 papers that have together received 9.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (194 papers), Chronic Lymphocytic Leukemia Research (67 papers), Viral-associated cancers and disorders (58 papers), CNS Lymphoma Diagnosis and Treatment (39 papers), Lung Cancer Treatments and Mutations (39 papers), CAR-T cell therapy research (32 papers), Hematopoietic Stem Cell Transplantation (21 papers) and Cancer Treatment and Pharmacology (20 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.6k citations), Genetics (2.4k citations), Oncology (5.3k citations), Neurology (1.5k citations) and Hematology (1.0k citations). Michael Crump has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include John Kuruvilla, Armand Keating, Melania Pintilie, Richard Tsang, Christian Gisselbrecht, David Hodgson, Mary Gospodarowicz, Woodrow Wells, Bertrand Coiffier and Annette E. Hay. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.